pl

Zarejestruj się
Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów.

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

Strona główna・Stock List・Voyager Therapeutics Inc
Search

Voyager Therapeutics Inc

Open

6.7 -4.29

Strong Buy

Price update 4 lis 2024, 20:52 UTC

BuySell

Overview

Share price change

24h

Current

Min

6.7

Max

7.17

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+140.43 upside

Dividends

By Dow Jones

Next Earnings

4 lis 2024

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

6.43 / 6.84 Support & Resistance

Voyager Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

2 sty 2024, 12:31 UTC

Major Market Movers

Voyager Therapeutics Shares Leap Premarket on Novartis Collaboration

DJ

Read

29 paź 2024, 21:31 UTC

Top News

AbbVie's Deal for Alzheimer's Antibody Raises Curtain for Roche News on Wednesday -- Barrons.com

DJ

Read

Peer Comparison

Price change

Voyager Therapeutics Inc Forecast

Price Target

By TipRanks

140.43% upside

12 Months Forecast

Average 16.83 USD  140.43%

High 30 USD

Low 7 USD

Based on 9 Wall Street analysts offering 12 month price targets forVoyager Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

8

Buy

1

Hold

0

Sell

Based on 9 analysts giving stock ratings to Voyager Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

6.43 / 6.84Support & Resistance

Short Term

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Long Term

Weak Bearish Evidence

Recent bearish events outweigh bullish events.

Financials

$

Other stocks from the sector

LLY

Eli Lilly and Co.

805.71

↓-1.45%

UNH

UnitedHealth Group Inc

556.95

↓-1.68%

JNJ

Johnson and Johnson

158.12

↓-1.16%

NVO

Novo Nordisk A-S

109.92

↓-1.81%

ABBV

AbbVie Inc

200.71

↓-1.24%